Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Brigham and Women's Hospital
Hoffmann-La Roche
Psyence Australia Pty Ltd
Daiichi Sankyo
Mayo Clinic
Bayer
Tempus AI
Institut Bergonié
Maria Sklodowska-Curie National Research Institute of Oncology
University Health Network, Toronto
SOLTI Breast Cancer Research Group
Astellas Pharma Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Convalife (Shanghai) Co., Ltd.
Hoffmann-La Roche
Jules Bordet Institute
Duke University
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
Eli Lilly and Company
DEKK-TEC, Inc.
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of California, San Francisco
Icahn School of Medicine at Mount Sinai
Merck Sharp & Dohme LLC
Novartis
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
Pharmacyclics LLC.
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Pfizer